The global Pets NSAIDs market size was valued at US$ 422.6 million in 2023. With growing demand in downstream market, the Pets NSAIDs is forecast to a readjusted size of US$ 640.5 million by 2030 with a CAGR of 6.1% during review period.
The research report highlights the growth potential of the global Pets NSAIDs market. Pets NSAIDs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pets NSAIDs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pets NSAIDs market.
Veterinary nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to control fever, pain, and other signs of inflammation in animals. Inflammation is the body's response to irritation or injury and results in redness, warmth, swelling, and pain in the inflamed area.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly 鈧�6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 43%.
Key Features:
The report on Pets NSAIDs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pets NSAIDs market. It may include historical data, market segmentation by Type (e.g., Injection Type, Oral Type), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pets NSAIDs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pets NSAIDs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pets NSAIDs industry. This include advancements in Pets NSAIDs technology, Pets NSAIDs new entrants, Pets NSAIDs new investment, and other innovations that are shaping the future of Pets NSAIDs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pets NSAIDs market. It includes factors influencing customer ' purchasing decisions, preferences for Pets NSAIDs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pets NSAIDs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pets NSAIDs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pets NSAIDs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pets NSAIDs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pets NSAIDs market.
Market Segmentation:
Pets NSAIDs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Injection Type
Oral Type
Others
Segmentation by application
Pet Hospital
Pet Shop
Household Use
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Bayer
JandJ
GSK
Septodont
Roche
PerioChip
Mobic
Rimadyl
Vetprofen
Novox
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pets NSAIDs market?
What factors are driving Pets NSAIDs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pets NSAIDs market opportunities vary by end market size?
How does Pets NSAIDs break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pets NSAIDs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Pets NSAIDs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Pets NSAIDs by Country/Region, 2019, 2023 & 2030
2.2 Pets NSAIDs Segment by Type
2.2.1 Injection Type
2.2.2 Oral Type
2.2.3 Others
2.3 Pets NSAIDs Sales by Type
2.3.1 Global Pets NSAIDs Sales Market Share by Type (2019-2024)
2.3.2 Global Pets NSAIDs Revenue and Market Share by Type (2019-2024)
2.3.3 Global Pets NSAIDs Sale Price by Type (2019-2024)
2.4 Pets NSAIDs Segment by Application
2.4.1 Pet Hospital
2.4.2 Pet Shop
2.4.3 Household Use
2.5 Pets NSAIDs Sales by Application
2.5.1 Global Pets NSAIDs Sale Market Share by Application (2019-2024)
2.5.2 Global Pets NSAIDs Revenue and Market Share by Application (2019-2024)
2.5.3 Global Pets NSAIDs Sale Price by Application (2019-2024)
3 Global Pets NSAIDs by Company
3.1 Global Pets NSAIDs Breakdown Data by Company
3.1.1 Global Pets NSAIDs Annual Sales by Company (2019-2024)
3.1.2 Global Pets NSAIDs Sales Market Share by Company (2019-2024)
3.2 Global Pets NSAIDs Annual Revenue by Company (2019-2024)
3.2.1 Global Pets NSAIDs Revenue by Company (2019-2024)
3.2.2 Global Pets NSAIDs Revenue Market Share by Company (2019-2024)
3.3 Global Pets NSAIDs Sale Price by Company
3.4 Key Manufacturers Pets NSAIDs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pets NSAIDs Product Location Distribution
3.4.2 Players Pets NSAIDs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pets NSAIDs by Geographic Region
4.1 World Historic Pets NSAIDs Market Size by Geographic Region (2019-2024)
4.1.1 Global Pets NSAIDs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Pets NSAIDs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Pets NSAIDs Market Size by Country/Region (2019-2024)
4.2.1 Global Pets NSAIDs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Pets NSAIDs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pets NSAIDs Sales Growth
4.4 APAC Pets NSAIDs Sales Growth
4.5 Europe Pets NSAIDs Sales Growth
4.6 Middle East & Africa Pets NSAIDs Sales Growth
5 Americas
5.1 Americas Pets NSAIDs Sales by Country
5.1.1 Americas Pets NSAIDs Sales by Country (2019-2024)
5.1.2 Americas Pets NSAIDs Revenue by Country (2019-2024)
5.2 Americas Pets NSAIDs Sales by Type
5.3 Americas Pets NSAIDs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pets NSAIDs Sales by Region
6.1.1 APAC Pets NSAIDs Sales by Region (2019-2024)
6.1.2 APAC Pets NSAIDs Revenue by Region (2019-2024)
6.2 APAC Pets NSAIDs Sales by Type
6.3 APAC Pets NSAIDs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pets NSAIDs by Country
7.1.1 Europe Pets NSAIDs Sales by Country (2019-2024)
7.1.2 Europe Pets NSAIDs Revenue by Country (2019-2024)
7.2 Europe Pets NSAIDs Sales by Type
7.3 Europe Pets NSAIDs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pets NSAIDs by Country
8.1.1 Middle East & Africa Pets NSAIDs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Pets NSAIDs Revenue by Country (2019-2024)
8.2 Middle East & Africa Pets NSAIDs Sales by Type
8.3 Middle East & Africa Pets NSAIDs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pets NSAIDs
10.3 Manufacturing Process Analysis of Pets NSAIDs
10.4 Industry Chain Structure of Pets NSAIDs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pets NSAIDs Distributors
11.3 Pets NSAIDs Customer
12 World Forecast Review for Pets NSAIDs by Geographic Region
12.1 Global Pets NSAIDs Market Size Forecast by Region
12.1.1 Global Pets NSAIDs Forecast by Region (2025-2030)
12.1.2 Global Pets NSAIDs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pets NSAIDs Forecast by Type
12.7 Global Pets NSAIDs Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Pets NSAIDs Product Portfolios and Specifications
13.1.3 Merck Pets NSAIDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Pets NSAIDs Product Portfolios and Specifications
13.2.3 Bayer Pets NSAIDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 JandJ
13.3.1 JandJ Company Information
13.3.2 JandJ Pets NSAIDs Product Portfolios and Specifications
13.3.3 JandJ Pets NSAIDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 JandJ Main Business Overview
13.3.5 JandJ Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK Pets NSAIDs Product Portfolios and Specifications
13.4.3 GSK Pets NSAIDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Septodont
13.5.1 Septodont Company Information
13.5.2 Septodont Pets NSAIDs Product Portfolios and Specifications
13.5.3 Septodont Pets NSAIDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Septodont Main Business Overview
13.5.5 Septodont Latest Developments
13.6 Roche
13.6.1 Roche Company Information
13.6.2 Roche Pets NSAIDs Product Portfolios and Specifications
13.6.3 Roche Pets NSAIDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Roche Main Business Overview
13.6.5 Roche Latest Developments
13.7 PerioChip
13.7.1 PerioChip Company Information
13.7.2 PerioChip Pets NSAIDs Product Portfolios and Specifications
13.7.3 PerioChip Pets NSAIDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 PerioChip Main Business Overview
13.7.5 PerioChip Latest Developments
13.8 Mobic
13.8.1 Mobic Company Information
13.8.2 Mobic Pets NSAIDs Product Portfolios and Specifications
13.8.3 Mobic Pets NSAIDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Mobic Main Business Overview
13.8.5 Mobic Latest Developments
13.9 Rimadyl
13.9.1 Rimadyl Company Information
13.9.2 Rimadyl Pets NSAIDs Product Portfolios and Specifications
13.9.3 Rimadyl Pets NSAIDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Rimadyl Main Business Overview
13.9.5 Rimadyl Latest Developments
13.10 Vetprofen
13.10.1 Vetprofen Company Information
13.10.2 Vetprofen Pets NSAIDs Product Portfolios and Specifications
13.10.3 Vetprofen Pets NSAIDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Vetprofen Main Business Overview
13.10.5 Vetprofen Latest Developments
13.11 Novox
13.11.1 Novox Company Information
13.11.2 Novox Pets NSAIDs Product Portfolios and Specifications
13.11.3 Novox Pets NSAIDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Novox Main Business Overview
13.11.5 Novox Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
